Todd Sherer, Ph.D. Vice President of Research Programs, the Michael J. Fox Foundation for Parkinson's Research, New York, USA. At the Michael J. Fox Foundation for Parkinson's Research ...

“LRRK2 continues to be a prominent target in Parkinson’s research, and a priority area of focus for disease-modifying therapies,” said Todd Sherer, Ph.D., Chief Mission Officer of The Michael ...

“LRRK2 continues to be a prominent target in Parkinson’s research, and a priority area of focus for disease-modifying therapies,” said Todd Sherer, Ph.D., Chief Mission Officer of The Michael J. Fox ...